Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood

  • Edit Bardi
  • Leo Kager


Survival after childhood cancer has improved substantially; therefore, the number of childhood cancer survivors is increasing. This growing population of childhood cancer survivors, however, is at risk of a spectrum of adverse health outcomes. Unfortunately, until now, there was a lack of comprehensive follow-up recommendations. The purpose of this article is to provide information on recently developed harmonized evidence-based guidelines on surveillance investigations to screen for the early detection of breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian failure in childhood cancer survivors. We point out the need for a multidisciplinary pediatric and adult specialist team, who together develop multidisciplinary long-term follow-up clinics.


Breast cancer Cardiomyopathy Premature ovarian failure Male gonadotoxicity Childhood cancer survivor 


Conflict of interest

E. Bardi and L. Kager declare that they have no competing interests.


  1. 1.
    Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):35–47.CrossRefPubMedGoogle Scholar
  2. 2.
    Howlander N, et al. SEER cancer statistics review 1975–2010. 2012. Accessed 31 Oct 2014.Google Scholar
  3. 3.
  4. 4.
    Madanat-Harjuoja LM, Pokhrel A, Kivivouri SM, Saarinen-Pihkala UM. Childhood cancer survival in Finland (1953–2010): a nation-wide population-based study. Int J Cancer. 2014;135(9):2129–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer. 2009;45(6):992–1005.CrossRefPubMedGoogle Scholar
  6. 6.
    Vassal G, Fitzgerald E, Schrappe M, et al. Challenges for children and adolescents with cancer in europe: the SIOP-europe agenda. Pediatr Blood Cancer. 2014;61(9):1551–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Hjorth L, Haup R, Skinner R, et al. Survivorship after childhood cancer: pancare: a European network to promote optimal long-term care. Eur J Cancer. 2015;51(10):1203–11.CrossRefPubMedGoogle Scholar
  9. 9.
    Kremer LCM, Mulder RL, Oeffinger KC, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60:543–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med. 2010;152:444–55.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Begg CB, Haile RW, Borg A, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008;299:194–201.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Moskowitz CS, Chou JF, Wolden SL, et al. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014;32(21):2217–23.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Mulder RL, Kremer LC, Hudson MM, et al. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2013;14(13):e621–e9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Basic Cardiovascular Sciences, Council on Cardiovascular Radiolo, Lipshultz SE, Adams MJ, Colan SD, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128:1927–95.CrossRefGoogle Scholar
  15. 15.
    Adams MJ, Lipshultz SE. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer. 2005;44:600–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Armenian SH, Hudson MM, Mulder RL, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16(3):e123–e36.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5‑year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2328–38.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Skinner R, Mulder RL, Kremer LC, et al. Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol. 2017;18(2):e75–e90.CrossRefPubMedGoogle Scholar
  20. 20.
    van Dorp W, Mulder RL, Kremer LC, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the international late effects of childhood cancer guideline harmonization group in collaboration with the pancareSurFup consortium. J Clin Oncol. 2016;34(28):3440–50.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    McCabe MS, Partridge AH, Grunfeld E, Hudson MM. Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013;40(6):804–12.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006.Google Scholar
  23. 23.
    Hewitt M, Weiner SL, Simone JV. Childhood cancer survivorship: improving care and quality of life. Washington, D.C.: The National Academies Press; 2003.Google Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Kepler UniversitätsklinikumLinzAustria
  2. 2.St. Anna Kinderspital, UKKJMedizinische Universität WienViennaAustria
  3. 3.Children’s Cancer Research InstituteViennaAustria

Personalised recommendations